PureTech Health (LSE:PRTC): Can Its Founded Entities Close The Valuation Gap After The Half-Year Report?

PureTech Health (LSE:PRTC): Can Its Founded Entities Close The Valuation Gap After The Half-Year Report? →

Highlights PureTech released its half-year report this week, detailing progress across its Founded Entities. Seaport Therapeutics listed on [Nasdaq], Celea began a Phase III trial and Gallop won FDA Fast Track designation. Management report…